CYP3A4 and Parkinson disease: similar molecules are shown active in CYP3A4 confirmation assay (important in drug metabolism); CYP2C9 (metabolizes NSAIDS and sulfonlyureas); BAP1 inhibition (tumor suppressor involved in breast cancer BRCA1); probes of Alpha-Synuclein 5'UTR (related to Parkinsons disease); FPR (GPCR involved in chemotaxis); antibacterial activity (Mycobacterium tuberculosis and VIM-2 metallo-beta-lactamase)